Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
allogeneic CAR-T cell therapy
|
| gptkbp:amendedBy |
gene-edited
|
| gptkbp:antigen |
gptkb:CD123
|
| gptkbp:cellType |
cell surface receptor
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Cellectis
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCART123
|
| gptkbp:indication |
gptkb:acute_myeloid_leukemia
gptkb:blastic_plasmacytoid_dendritic_cell_neoplasm |
| gptkbp:mechanismOfAction |
targets and kills CD123-expressing cells
|
| gptkbp:origin |
donor-derived
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:technology |
gptkb:TALEN_gene_editing
|
| gptkbp:bfsParent |
gptkb:Cellectis
|
| gptkbp:bfsLayer |
7
|